Veracyte, Inc.
VCYT
$46.41
$0.140.30%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 15.49% | 21.49% | 18.55% | 13.82% | 13.75% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 15.49% | 21.49% | 18.55% | 13.82% | 13.75% |
| Cost of Revenue | 3.37% | 8.72% | -3.40% | 14.98% | 12.46% |
| Gross Profit | 19.81% | 26.52% | 32.93% | 13.41% | 14.22% |
| SG&A Expenses | -2.93% | -12.75% | 13.59% | 5.82% | 4.93% |
| Depreciation & Amortization | -3.83% | 2.46% | -7.76% | -12.33% | -13.25% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.80% | 4.35% | 4.73% | 5.31% | 5.47% |
| Operating Income | 50.82% | 679.82% | 213.38% | 83.71% | 178.91% |
| Income Before Tax | 2,021.84% | 303.53% | 1,080.19% | 12.11% | -83.02% |
| Income Tax Expenses | -53.68% | 232.55% | 69.16% | -114.65% | 37.06% |
| Earnings from Continuing Operations | 2,701.02% | 307.36% | 704.79% | 26.28% | -117.09% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 2,701.02% | 307.36% | 704.79% | 26.28% | -117.09% |
| EBIT | 50.82% | 679.82% | 213.38% | 83.71% | 178.91% |
| EBITDA | 34.22% | 239.66% | 112.03% | 53.74% | 85.04% |
| EPS Basic | 2,649.60% | 299.67% | 688.62% | 23.53% | -116.69% |
| Normalized Basic EPS | 19.55% | 295.80% | 285.71% | 44.73% | 158.42% |
| EPS Diluted | 2,580.00% | 288.89% | 711.58% | 26.32% | -117.86% |
| Normalized Diluted EPS | 16.49% | 297.24% | 286.71% | 45.71% | 160.36% |
| Average Basic Shares Outstanding | 2.02% | 1.93% | 2.02% | 2.22% | 2.42% |
| Average Diluted Shares Outstanding | 4.68% | 1.57% | 1.85% | 1.56% | 1.59% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |